133 related articles for article (PubMed ID: 22367918)
1. Diagnostic value of K-ras mutation analysis for pancreaticobiliary cytology specimens with indeterminate diagnosis.
Cai G; Mahooti S; Lipata FM; Chhieng D; Hui P
Cancer Cytopathol; 2012 Oct; 120(5):313-8. PubMed ID: 22367918
[TBL] [Abstract][Full Text] [Related]
2. The utility of Ki-ras mutation analysis in the cytologic diagnosis of pancreatobiliary neoplasma.
Dillon DA; Johnson CC; Topazian MD; Tallini G; Rimm DL; Costa JC
Cancer J; 2000; 6(5):294-301. PubMed ID: 11079168
[TBL] [Abstract][Full Text] [Related]
3. Use of microsatellite marker loss of heterozygosity in accurate diagnosis of pancreaticobiliary malignancy from brush cytology samples.
Khalid A; Pal R; Sasatomi E; Swalsky P; Slivka A; Whitcomb D; Finkelstein S
Gut; 2004 Dec; 53(12):1860-5. PubMed ID: 15542529
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of K-ras codon 12 analysis and endobiliary brush cytology for the diagnosis of malignant extrahepatic bile duct stenosis.
Sturm PD; Rauws EA; Hruban RH; Caspers E; Ramsoekh TB; Huibregtse K; Noorduyn LA; Offerhaus GJ
Clin Cancer Res; 1999 Mar; 5(3):629-35. PubMed ID: 10100716
[TBL] [Abstract][Full Text] [Related]
5. A comparative analysis of pancreas cyst fluid CEA and histology with DNA mutational analysis in the detection of mucin producing or malignant cysts.
Sreenarasimhaiah J; Lara LF; Jazrawi SF; Barnett CC; Tang SJ
JOP; 2009 Mar; 10(2):163-8. PubMed ID: 19287110
[TBL] [Abstract][Full Text] [Related]
6. Molecular diagnostic testing as an adjunct to morphologic evaluation of pancreatic ductal system brushings: potential augmentation for diagnostic sensitivity.
Willmore-Payne C; Volmar KE; Huening MA; Holden JA; Layfield LJ
Diagn Cytopathol; 2007 Apr; 35(4):218-24. PubMed ID: 17351944
[TBL] [Abstract][Full Text] [Related]
7. DNA mutational differences in cytological specimens from pancreatic cancer and cholangiocarcinoma.
Fasanella KE; Krasinskas A; Schoedel KE; Sasatomi E; Slivka A; Whitcomb DC; Sanders M; Nodit L; Raab S; McGrath KM; Ohori NP; Khalid A
Pancreatology; 2010; 10(4):429-33. PubMed ID: 20720444
[TBL] [Abstract][Full Text] [Related]
8. Ki-ras mutations in codon 12 and p53 mutations (biomarkers) and cytology in bile in patients with hepatobiliary-pancreatic carcinoma.
Yamaguchi K; Nakano K; Nagai E; Chijiiwa K; Kinoshita M; Ohta M; Tanaka M
Hepatogastroenterology; 2005; 52(63):713-8. PubMed ID: 15966189
[TBL] [Abstract][Full Text] [Related]
9. Detection of K-ras mutations in the stool of patients with pancreatic adenocarcinoma and pancreatic ductal hyperplasia.
Caldas C; Hahn SA; Hruban RH; Redston MS; Yeo CJ; Kern SE
Cancer Res; 1994 Jul; 54(13):3568-73. PubMed ID: 8012983
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Intraductal Ultrasonography, Endoscopic Brush Cytology and K-ras, P53 Gene Mutation in the Early Diagnosis of Malignant Bile Duct Stricture.
Huang P; Zhang H; Zhang XF; Zhang X; Lyu W; Fan Z
Chin Med J (Engl); 2015 Jul; 128(14):1887-92. PubMed ID: 26168827
[TBL] [Abstract][Full Text] [Related]
11. Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic masses.
Ogura T; Yamao K; Sawaki A; Mizuno N; Hara K; Hijioka S; Niwa Y; Tajika M; Kondo S; Shimizu Y; Bhatia V; Higuchi K; Hosoda W; Yatabe Y
Gastrointest Endosc; 2012 Apr; 75(4):769-74. PubMed ID: 22284089
[TBL] [Abstract][Full Text] [Related]
12. The potential diagnostic use of K-ras codon 12 and p53 alterations in brush cytology from the pancreatic head region.
Sturm PD; Hruban RH; Ramsoekh TB; Noorduyn LA; Tytgat GN; Gouma DJ; Offerhaus GJ
J Pathol; 1998 Nov; 186(3):247-53. PubMed ID: 10211112
[TBL] [Abstract][Full Text] [Related]
13. Analysis of loss of heterozygosity in atypical and negative bile duct brushing cytology specimens with malignant outcome: are "false-negative" cytologic findings a representation of morphologically subtle molecular alterations?
Krishnamurti U; Sasatomi E; Swalsky PA; Finkelstein SD; Ohori NP
Arch Pathol Lab Med; 2007 Jan; 131(1):74-80. PubMed ID: 17227126
[TBL] [Abstract][Full Text] [Related]
14. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas.
Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M
Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672
[TBL] [Abstract][Full Text] [Related]
15. Single-pattern convergence of K-ras mutation correlates with surgical indication of intraductal papillary mucinous neoplasms.
Mizuno O; Kawamoto H; Yamamoto N; Horiguchi S; Tsutsumi K; Fujii M; Kato H; Hirao K; Kurihara N; Ishida E; Ogawa T; Okada H; Yamamoto K
Pancreas; 2010 Jul; 39(5):617-21. PubMed ID: 20173673
[TBL] [Abstract][Full Text] [Related]
16. The K-ras mutation pattern in pancreatic ductal adenocarcinoma usually is identical to that in associated normal, hyperplastic, and metaplastic ductal epithelium.
Lüttges J; Schlehe B; Menke MA; Vogel I; Henne-Bruns D; Klöppel G
Cancer; 1999 Apr; 85(8):1703-10. PubMed ID: 10223563
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the novel quantitative ARMS assay and an enriched PCR-ASO assay for K-ras mutations with conventional cytology on endobiliary brush cytology from 312 consecutive extrahepatic biliary stenoses.
van Heek NT; Clayton SJ; Sturm PD; Walker J; Gouma DJ; Noorduyn LA; Offerhaus GJ; Fox JC
J Clin Pathol; 2005 Dec; 58(12):1315-20. PubMed ID: 16311354
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of K-ras point mutation, telomerase activity, and p53 overexpression in pancreatic tumours.
Uemura K; Hiyama E; Murakami Y; Kanehiro T; Ohge H; Sueda T; Yokoyama T
Oncol Rep; 2003; 10(2):277-83. PubMed ID: 12579258
[TBL] [Abstract][Full Text] [Related]
19. Classification of probe-based confocal laser endomicroscopy findings in pancreaticobiliary strictures.
Meining A; Shah RJ; Slivka A; Pleskow D; Chuttani R; Stevens PD; Becker V; Chen YK
Endoscopy; 2012 Mar; 44(3):251-7. PubMed ID: 22261749
[TBL] [Abstract][Full Text] [Related]
20. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
